Log In Request A Free Trial |
Customer support: +44 (0)20 7017 7701 Technical Support: +44 (0) 20 7017 4161
Home | Help | FAQs
Search:
Advanced | Case
Go
You are here:
Home » Publications » Liability Risk and Insurance » 2009 » November » Document

Related Content

Publication Details
Liability Risk and Insurance
ISSUE: 231
ISBN: 0960 099X

17 Nov 2009Liability Risk and Insurance

US$2.5mn in damages over Seroxat in US

The parents of a young child have been awarded US$2.5mn in damages after a jury in Philadelphia decided that the antidepressant Seroxat was responsible for their three-year-old son’s heart defects. Seroxat, known as Paxil in the US, is an antidepressant manufactured by the British pharmaceutical company, GlaxoSmithKline, which said it would appeal against the verdict.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Username:
Password:
Email address:
Log in
Remember my details on this computer:

If you are not already a subscriber, please select one of the options below.

Sign up for a free trial or for further assistance call your Account Manager or our Customer support: +44 (0)20 7017 7701 Technical Support: +44 (0) 20 7017 4161 .

Lloyd's and the Lloyd's Crest are trademarks of the Society incorporated by the Lloyd's Act 1871 by the name of Lloyd's
Terms and Conditions | Copyright | Contact | Trial/Subscribe

In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way www.i-law.com uses cookies please go to our Cookie Policy page.

By closing this message, you are consenting to our use of cookies.